Jurjen Versluis (@jurjenversluis) 's Twitter Profile
Jurjen Versluis

@jurjenversluis

ID: 1672284099338203137

calendar_today23-06-2023 16:43:27

22 Tweet

90 Followers

59 Following

Ruud Delwel (@delwelruud) 's Twitter Profile Photo

September 18th, we will continue the Erasmus Virtual Hematology Lecture series with Kathrin Bernt. We will continue the 2023 series with Michael Kharas, Giada Bianchi, Coleman Lindsley, Alba Rodriquez-Meira and Katherine King! Always on a Monday at 16.00 CET! Spread the news!

September 18th, we will continue the Erasmus Virtual Hematology Lecture series with Kathrin Bernt. We will continue the 2023 series with Michael Kharas, Giada Bianchi, Coleman Lindsley, Alba Rodriquez-Meira and Katherine King! Always on a Monday at 16.00 CET!
Spread the news!
Amer Zeidan MBBS,MHS ‏عامر زيدان (@dr_amerzeidan) 's Twitter Profile Photo

Important alert to all transplanters! Every #TransplantAllogeneic Doc who sees #MDSsm patients should read this paper by ⁦Coleman Lindsley⁩ !! Please do NOT decline to transplant otherwise eligible TP53-mut higher risk #MDSsm Pts who have donors ascopubs.org/doi/10.1200/JC…

Jurjen Versluis (@jurjenversluis) 's Twitter Profile Photo

External (Real-world) Control Data are increasingly being used in Hem/Onc research. But do they live up to expectations? Check out this important review by Niek van der Maas and Sjoerd Hermans, now in JAMA Oncology!

paresh vyas (@pvyas_oxford) 's Twitter Profile Photo

Really pleased to share this clinically important collaborative study between UK AmML Clinical Trial Group and Hovon. The first of many future pan-European collaborative studies in AML and High risk MDS